Simcere Pharmaceutical : RESIGNATION OF EXECUTIVE DIRECTOR AND CHIEF OPERATING OFFICER

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Simcere Pharmaceutical Group Limited

先聲藥業集團有限公司

(Incorporated in Hong Kong with limited liability)

(Stock code: 2096)

RESIGNATION OF EXECUTIVE DIRECTOR AND

CHIEF OPERATING OFFICER

The board (the "Board") of directors (the "Directors" and each a "Director") of Simcere Pharmaceutical Group Limited (the "Company") hereby announces that Mr. ZHANG Cheng ("Mr. Zhang") has tendered his resignation as an executive Director and the chief operating officer of the Company to the Board with effect from March 31, 2021 due to his personal career development.

Mr. Zhang has confirmed that he has no disagreement with the Board and there is no other matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company.

The Board would like to take this opportunity to express its sincere gratitude to Mr. Zhang for his contributions to the Company during his tenure of office.

By order of the Board of

Simcere Pharmaceutical Group Limited

Mr. Ren Jinsheng

Chairman and executive Director

Hong Kong, March 31, 2021

As at the date of this announcement, the Board comprises Mr. REN Jinsheng as the Chairman and executive Director, Mr. WAN Yushan and Mr. TANG Renhong as the executive Directors; Mr. ZHAO John Huan as the non-executive Director; and Mr. SONG Ruilin, Mr. WANG Jianguo and Mr. WANG Xinhua as the independent non-executive Directors.